View Post

Oral COVID-19 Therapy Offers Measurable Benefits

In COVID-19, Latest News by Precision Vaccinations

A recent conversation with Dr. John Farley, director of the U.S. FDA’s Office of Infectious Diseases, provided insights regarding Paxlovid, the preferred oral therapy for managing non-hospitalized adults with COVID-19.
The antiviral Paxlovid reduces the risk of hospitalization and death for patients with mild-to-moderate COVID-19 at high risk of disease progression. 

View Post

427 Acute Liver Cases in Children Continue Baffling Health Experts

In COVID-19, Latest News by Precision Vaccinations

Health experts across the globe recently issued updates on the ongoing investigation into liver inflammation in children.
On May 6, 2022, the U.S. Centers for Disease Control and Prevention (CDC) confirmed that the unexplained acute liver cases in children had reached 24 states and Puerto Rico.
The CDC confirmed there are now 109 known pediatric liver cases of unknown cause. Unfortunately, there have been seven liver transplants and five related fatalities since October 2021.